AGIOS PHARMACEUTICALS, INC. Stock Split Ratio
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Stock Split Ratio of 275.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2016-02-26
- AGIOS PHARMACEUTICALS, INC. stockholders' equity note, stock split, conversion ratio for the quarter ending 2014-03-31 was 36.36%.
- AGIOS PHARMACEUTICALS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 275.00%, a 0.00% change from fiscal 2014.
- AGIOS PHARMACEUTICALS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2014 was 275.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2015-12-31 | 275.00% 10-K · filed 2016-02-26 | |||
| 2014-12-31 | 275.00% 10-K · filed 2015-02-24 | |||
| 2014-09-30 | 36.36% 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | 36.36% 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | 36.36% 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |